Shares of Clover Health Investments, Corp. (NASDAQ:CLOV - Get Free Report) hit a new 52-week high during mid-day trading on Monday . The company traded as high as $2.93 and last traded at $2.93, with a volume of 383715 shares trading hands. The stock had previously closed at $2.83.
Clover Health Investments Trading Up 12.4 %
The firm has a market cap of $1.58 billion, a PE ratio of -9.35 and a beta of 2.10. The firm's 50 day simple moving average is $1.54 and its 200 day simple moving average is $1.09.
Clover Health Investments (NASDAQ:CLOV - Get Free Report) last issued its earnings results on Monday, August 5th. The company reported $0.01 EPS for the quarter, topping analysts' consensus estimates of ($0.04) by $0.05. Clover Health Investments had a negative net margin of 8.63% and a negative return on equity of 48.07%. The business had revenue of $356.26 million for the quarter, compared to the consensus estimate of $338.70 million. During the same period in the prior year, the firm earned ($0.06) EPS. As a group, equities research analysts predict that Clover Health Investments, Corp. will post -0.21 earnings per share for the current fiscal year.
Institutional Trading of Clover Health Investments
A number of hedge funds and other institutional investors have recently made changes to their positions in the business. XTX Topco Ltd acquired a new position in Clover Health Investments during the second quarter worth about $932,000. Jupiter Asset Management Ltd. increased its stake in Clover Health Investments by 18.1% during the 1st quarter. Jupiter Asset Management Ltd. now owns 4,525,079 shares of the company's stock worth $3,593,000 after buying an additional 692,878 shares during the period. Choreo LLC purchased a new stake in Clover Health Investments during the 2nd quarter worth approximately $344,000. Squarepoint Ops LLC increased its position in shares of Clover Health Investments by 220.7% in the 2nd quarter. Squarepoint Ops LLC now owns 130,352 shares of the company's stock valued at $160,000 after purchasing an additional 238,329 shares during the last quarter. Finally, Bayesian Capital Management LP purchased a new stake in shares of Clover Health Investments in the 1st quarter valued at approximately $142,000. Institutional investors and hedge funds own 19.77% of the company's stock.
About Clover Health Investments
(
Get Free Report)
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.
Featured Articles
Before you consider Clover Health Investments, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clover Health Investments wasn't on the list.
While Clover Health Investments currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
